By acquiring new accounts and expanding into NICUs managed by existing clients, Ceribell calculates it can unlock a $400 ...

The problem applies to Abbott’s Libre 3 and Libre 3 Plus sensors. The company said it has received reports of 736 severe adverse events and seven deaths.

The company named former Inari Medical CEO Drew Hykes as its next leader in conjunction with the financing round.

The medtech firm plans to launch its next flagship patch-pump in 2027, and its first fully closed loop system for Type 2 ...

GE HealthCare forecast Intelerad’s revenue to be approximately $270 million in the first full year of ownership. The deal ...

The proposed deal, the biggest under CEO Robert Ford’s tenure, would allow Abbott to enter a large, new market for cancer ...

The chief medical officer for the new J&J unit discussed intravascular lithotripsy’s rapid growth and what to expect from the ...

The company has stepped up its interest in M&A since making a $4.1 billion divestiture that strengthened its balance sheet.

Analysts said the deal shows Roche’s long-term strategy for its sequencing technology is “a clinical box for running NGS kits ...

The purchase would give Abbott access to cancer screening tests including Cologuard and blood tests for multi-cancer early ...

More generous subsidies for Affordable Care Act plans have helped millions of Americans afford insurance. Chances are ...

Artificial intelligence combines ultrasound and X-ray images to give physicians a real-time 3D view of the repair device ...